Syndrome of headache with neurologic deficits and CSF lymphocytosis (HaNDL)

por Skorobogatykh, K, Azimova, Y, Tabeeva, G
Publicado 2013

Predictive factors for the relapse medication overuse headache. A prospective study

por Sergeev, A, Mesherina, M, Tabeeva, G
Publicado 2013

EHMTI-0088. Prediction of treatment response in chronic daily headache patients (a prospective study)

por Golovacheva, V, Parfenov, V, Tabeeva, G
Publicado 2014

EHMTI-0207. Abnormal brain excitability and cognitive dysfunction in adolescents with chronic daily headache

por Sergeev, A, Ratchin, A, Avdeeva, T, Tabeeva, G
Publicado 2014

EHMTI-0135. Migraine outcomes and cortical excitability: analysis of pattern-reversal visual evoked potentials (PR-VEP)

por Sergeev, A, Snopkova, E, Tabeeva, G, Osipova, V
Publicado 2014

EHMTI-0015. Impact of headache-attributed burden on productivity and quality of life in russia: structured healthcare is urgently needed

por Ayzenberg, I, Katsarava, Z, Osipova, V, Tabeeva, G, Chernysh, M, Steiner, TJ
Publicado 2014

EHMTI-0208. Positive association between -1021C/T polymorphism of dopamine-b-hydroxylase gene and level substance dependence in medication-overuse headache

por Sergeev, A, Azimova, J, Klimov, E, Skorobogatykh, K, Kokaeva, Z, Kondratieva, N, Kochetkova, T, Tabeeva, G
Publicado 2014

EHMTI-0233. Clinical characteristics of migraine patients with dopaminergic gene polymorphisms RS1611115

por Skorobogatykh, K, Azimova, J, Sergeev, A, Klimov, E, Tabeeva, G, Fokina, N, Korobeynikova, L, Kokaeva, Z
Publicado 2014